Inhibitory effect of novel polyoxometalate on hepatitis B virus replication in vitro
Juan Li
Abstract
Juan Li
Abstract
Objective To evaluate the activity of novel polyoxometalate against hepatitis B virus (HBV) in vitro.Methods MTT assay was used to evaluate the growth inhibitory effects of polyoxometalate on 2.2.15 cell lines,Hepatitis B e(s) antigen(HBeAg) and Hepatitis B surface antigen in the culture medium were determined by ELISA.Southern blotting was performed to detect HBV DNA in Hep G2 2.2.15 cells.Real-time quantity PCR was applied to detect the contents of introcellular HBV mRNA and extracellular HBV DNA.Results The median toxicity concentration(TC50) was 1590.46 mg·L-1 on 2.2.15 cells.The inhibitory rats of PTW-6 on HBeAg and HBsAg were markedly higher compared with control group(P0.05).The median inhibitory concentration(IC50) of PTE-6 in extracellular HBV DNA and introcellular HBV mRNA were 51.1 and 63.6 mg·L-1,respectively.Conclusion Novel polyoxometalate is a potential compound for treatment chronic HBV infection.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the activity of novel polyoxometalate against hepatitis B virus (HBV) in vitro.Methods MTT assay was used to evaluate the growth inhibitory effects of polyoxometalate on 2.2.15 cell lines,Hepatitis B e(s) antigen(HBeAg) and Hepatitis B surface antigen in the culture medium were determined by ELISA.Southern blotting was performed to detect HBV DNA in Hep G2 2.2.15 cells.Real-time quantity PCR was applied to detect the contents of introcellular HBV mRNA and extracellular HBV DNA.Results The median toxicity concentration(TC50) was 1590.46 mg·L-1 on 2.2.15 cells.The inhibitory rats of PTW-6 on HBeAg and HBsAg were markedly higher compared with control group(P0.05).The median inhibitory concentration(IC50) of PTE-6 in extracellular HBV DNA and introcellular HBV mRNA were 51.1 and 63.6 mg·L-1,respectively.Conclusion Novel polyoxometalate is a potential compound for treatment chronic HBV infection.
Key concepts: HBeAg, HBsAg, Hepatitis B virus, In vitro, Virology, Molecular biology, IC50, Extracellular